Baclofen is a prescription muscle relaxant commonly used to treat spasticity caused by conditions such as multiple sclerosis, spinal cord injuries, or cerebral palsy. It works by acting on the central nervous system, specifically targeting GABA receptors, to reduce the transmission of nerve signals that lead to muscle stiffness and spasms. While it can be effective in improving mobility and comfort, it may cause side effects like drowsiness, dizziness, weakness, and fatigue. It is important to use Baclofen exactly as prescribed, as stopping it suddenly can lead to serious withdrawal symptoms such as seizures or hallucinations.
BRAND NAMES
Baclofen is marketed under several brand names, the most common being Lioresal for oral use and Gablofen or Lioresal Intrathecal for administration through a spinal pump in severe cases. These brands are used to treat muscle spasticity, and many generic versions are also available worldwide.
Lioresal – one of the most widely known original brands
Gablofen – used for intrathecal (spinal pump) administration
Lioresal Intrathecal – specifically for severe spasticity via pump
Kemstro – previously marketed oral formulation
MECHANISM OF ACTION
Baclofen works by acting on the central nervous system as an agonist of GABA-B receptors. It mimics the inhibitory neurotransmitter GABA, reducing the release of excitatory signals in the spinal cord. This leads to decreased nerve transmission to muscles, resulting in reduced muscle spasticity, relaxation of muscles, and improved movement.
PHARMACOKINETICS
Absorption
Baclofen is rapidly absorbed from the gut, with about 70–80% bioavailability. Peak blood levels occur in 2–3 hours, and food may slightly delay absorption without affecting the total amount absorbed.
Distribution
Baclofen is widely distributed throughout body tissues, including the brain and spinal cord, though its penetration into the central nervous system is moderate. It has a volume of distribution of approximately 0.7 L/kg. About 30% of the drug bindsto plasma proteins, allowing the rest to circulate freely to target tissues, particularly the spinal cord where it exerts its therapeutic effects.
Metabolism
Baclofen undergoes minimal metabolism in the liver. Most of the drug remains unchanged, with only a small fraction (about 5–15%) metabolized to inactive compounds. Because it is largely excreted unchanged by the kidneys, hepatic metabolism does not play a major role in its elimination.
Excretion
Baclofen is primarily excreted unchanged in the urine, accounting for about 70–80% of the administered dose. The renal clearance is significant, and the drug’s half-life is approximately 3–4 hours in individuals with normal kidney function. Impaired renal function can lead to accumulation, requiring dose adjustments to avoid toxicity.
PHARMACODYNAMICS
Baclofen works by activating GABA-B receptors in the spinal cord, reducing excitatory nerve signals to muscles. This leads to decreased muscle spasticity, improved movement, and overall muscle relaxation, with effects that are dose-dependent.
ADMINISTRATION
Baclofen is usually administered orally in tablet form, starting with a low dose that is gradually increased to minimize side effects. For severe spasticity unresponsive to oral therapy, it can be delivered intrathecally via a spinal pump, which allows direct delivery to the cerebrospinal fluid. Dosing should be individualized based on patient response and renal function, and abrupt discontinuation should be avoided to prevent withdrawal symptoms.
DOSAGE AND STRENGTH
Baclofen is available orally in 5 mg, 10 mg, and 20 mg tablets, usually starting at 5 mg three times daily and gradually increased. Maintenance doses typically range from 30–80 mg per day. For severe cases, it can be given intrathecally via a spinal pump, with doses individually adjusted.
FOOD INTERACTIONS
Food has minimal impact on baclofen’s absorption. While a high-fat meal may slightlydelay the time to reach peak blood levels, it does not significantly affect the overall bioavailability. Baclofen can generally be taken with or without foodto reduce gastrointestinal discomfort.
DRUG INTERACTIONS
Baclofen can interact with CNS depressants like sedatives, alcohol, or opioids, increasing drowsiness and dizziness. It may also enhance the effects of antihypertensives and accumulate in patients with impaired kidney function, so caution is needed when used with other muscle relaxants or renal-impacting drugs.
CONTRAINDICATIONS
Hypersensitivity to baclofen or any of its components
Severe renal impairment without dose adjustment, as accumulation can cause toxicity
Active peptic ulcer disease or gastrointestinal bleeding in some cases, due to potential exacerbation of symptoms
Epilepsy or seizure disorders unless carefully monitored, since abrupt changes can trigger seizures
SIDE EFFECTS
Drowsiness, dizziness, or fatigue
Weakness or muscle hypotonia
Nausea, vomiting, or constipation
Headache or insomnia
Less common but serious effects may include:
Hypotension
Hallucinations or confusion
Seizures (especially if abruptly discontinued)
Respiratory depression in overdose or sensitive patients
TOXICITY
Baclofen toxicity usually occurs due to overdoseor impaired renal clearance, as the drug is primarily excreted unchanged by the kidneys. Symptoms may include severe drowsiness, confusion, respiratory depression, hypotension, bradycardia, seizures, and coma. Abrupt withdrawal after long-term use can also cause hallucinations, muscle spasms, and rebound spasticity. Management typically involves supportive care, monitoring of vital signs, and, in severe cases, hemodialysis to remove the drug.
